Full-Time
Biomanufacturing technology to produce materials
No salary listed
Remote in USA + 1 more
More locations: Remote in Canada
Remote
InvertBio uses biology to produce materials and chemicals for industries that rely on physical inputs, offering biomanufacturing methods that enable greener, scalable production. Biological systems perform the making through bioprocesses like fermentation and enzyme pathways, turning living organisms into practical inputs produced more sustainably. Unlike traditional manufacturing, it emphasizes sustainable, scalable bio-based production to cut environmental impact and costs for manufacturing, agriculture, and pharmaceuticals. Its goal is to help industries transition to greener, cost-effective production by supplying biology-based materials and services that meet growing demand.
Company Size
11-50
Company Stage
Early VC
Total Funding
$20.3M
Headquarters
San Francisco, California
Founded
2021
Help us improve and share your feedback! Did you find this helpful?
Remote Work Options
Unlimited Paid Time Off
Company Equity
Invert has filed a notice of an exempt offering of securities to raise $20,100,000.00 in New Equity Investment. Invert has filed a notice of an exempt offering of securities to raise $20,100,000.00 in New Equity Investment.According to filings with the U.S. Securities and Exchange Commission, Invert is raising up to $20,100,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Martin Permin played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.About InvertInvert builds software for bioprocessing. With Invert, your team has full transparency into all your bioprocess data from lab to production, including full process traceability from upstream to formulation. Your team will save time juggling manual data, get to insights faster, and collaborate seamlessly across teams and partners
The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.
Reptile8488 (Canva)Do you remember when the first fully electric vehicles came out in the early 2000s, and we all said, "Neat, but where are you going to plug it in?" Now—pause for emphasis—a full two decades later—electric vehicles are starting to become commonplace, but they still only account for about 1% of US auto sales.Electricity is cool, as long as it doesn't come from burning coal, but what if our fuel sources could be not only carbon neutral but actually carbon negative? That is the promise of biology.Yeast, bacteria, plants, and algae can use a huge variety of fuel sources—sugar, organic waste, and even greenhouse gases – to produce molecules that we can use for fuel, medicine, plastics, building materials, clothing, cosmetics, and more."It requires a bunch of tinkering and some cell engineering. But you can get [microorganisms] to consume basically anything and make basically anything," said Joshua Lachter, Co-Founder of Synonym Bio, a financing and development platform for biomanufacturing. "That's the idea, the hope, and the dream.". SynBioBetaSynthetic biologists at universities and companies around the world have shown that we can use biomanufacturing to produce hundreds of materials that are currently unsustainably sourced. So, what's the hold-up?For electric vehicles to become more ubiquitous, two shifts have occurred: One in economics, fuel prices went up, and the cost of manufacturing electric vehicles went down; One in infrastructure, EV charging stations popped up everywhere from condos to coffee shops.In order for biomanufacturing to reach its full potential, we have to build an infrastructure, and it's got to be cheap